
Adicet Bio
(NASDAQ) ACET
Adicet Bio Financials at a Glance
Market Cap
$67.08M
Revenue (TTM)
$0.00
Net Income (TTM)
$116.80M
EPS (TTM)
$-18.10
P/E Ratio
-0.39
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Price
$6.99
Volume
64,015.573
Open
$6.81
Price
$6.99
Volume
64,015.573
Open
$6.81
Previous Close
$6.99
Daily Range
$6.74 - $7.01
52-Week Range
$6.01 - $17.44
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Price
$6.99
Volume
64,015.573
Open
$6.81
Previous Close
$6.99
Daily Range
$6.74 - $7.01
52-Week Range
$6.01 - $17.44
ACET News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Adicet Bio
Industry
Biotechnology
Sector
Health CareEmployees
102
CEO
Chen Schor, MBA, CPA
Website
www.adicetbio.comHeadquarters
Boston, MA 02116, US
ACET Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-68%
Return on Capital
-71%
Return on Assets
-61%
Earnings Yield
-2.56%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$67.08M
Shares Outstanding
9.60M
Volume
64.02K
Short Interest
0.00%
Avg. Volume
149.37K
Financials (TTM)
Gross Profit
$6.38M
Operating Income
$122.11M
EBITDA
$115.73M
Operating Cash Flow
$95.25M
Capital Expenditure
$1.74M
Free Cash Flow
$96.98M
Cash & ST Invst.
$158.53M
Total Debt
$14.74M
Adicet Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.47M
N/A
Gross Margin
0.00%
N/A
Market Cap
$67.08M
N/A
Market Cap/Employee
$441.31K
N/A
Employees
152
N/A
Net Income
$30.52M
-6.2%
EBITDA
$34.37M
-26.8%
Quarterly Fundamentals
Net Cash
$143.79M
-9.6%
Accounts Receivable
$342.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$11.55M
-18.1%
Short Term Debt
$3.19M
+1.7%
Return on Assets
-60.72%
N/A
Return on Invested Capital
-71.49%
N/A
Free Cash Flow
$20.90M
+13.9%
Operating Cash Flow
$20.91M
+13.2%



